Myocardial magnesium: relation to laboratory and clinical variables in patients undergoing cardiac surgery

Department of Cardiology, Marshfield Clinic, Wisconsin 54449.

Magnesium concentration was measured in the right atrial appendage of 100 patients undergoing cardiac surgery and associations with serum and mononuclear blood cell magnesium, other laboratory values and patient clinical variables were studied. In addition, magnesium was measured in the right atrial appendage and left ventricular free wall in 23 autopsy subjects to determine whether there was a proportional relation between right atrial appendage and left ventricular free wall magnesium. The mean left ventricular free wall/right atrial appendage magnesium ratio was 2.13 +/- 0.39 (r = 0.67, p = 0.0009). In the group with cardiac surgery, the right atrial appendage magnesium concentration correlated inversely with age (r = -0.54, p = 0.001). The mean right atrial appendage magnesium concentration (micrograms/g wet weight tissue) was lower in patients with postoperative cardiac arrhythmia than in those without arrhythmia (103 +/- 13 versus 111 +/- 10, p = 0.009) and in diabetic than in nondiabetic patients (103 +/- 13 versus 109 +/- 12, p = 0.02). The right atrial appendage magnesium concentration also tended to be lower in patients receiving potassium/magnesium-losing diuretics, although this difference did not achieve statistical significance (105 +/- 14 versus 109 +/- 11, p = 0.16). Right atrial appendage magnesium concentration correlated positively with serum creatinine concentration (r = 0.31, p = 0.002) and negatively with serum calcium concentration (r = -0.29, p = 0.013). Serum magnesium did not correlate with right atrial appendage or mononuclear blood cell magnesium concentration or clinical variables. There was a statistically significant correlation between mononuclear blood cell and right atrial appendage magnesium concentrations in some subgroups of patients.

This article has been cited by other articles:

				H. Kohno, T. Koyanagi, H. Kasegawa, and M. Miyazaki Three-Day Magnesium Administration Prevents Atrial Fibrillation After Coronary Artery Bypass Grafting Ann. Thorac. Surg., January 1, 2005; 79(1): 117 - 126. [Abstract] [Full Text] [PDF]

				F. Toraman, E. H. Karabulut, H. C. Alhan, S. Dagdelen, and S. Tarcan Magnesium infusion dramatically decreases the incidence of atrial fibrillation after coronary artery bypass grafting Ann. Thorac. Surg., October 1, 2001; 72(4): 1256 - 1262. [Abstract] [Full Text] [PDF]

				P. Brugada Magnesium: an antiarrhythmic drug, but only against very specific arrhythmias Eur. Heart J., July 2, 2000; 21(14): 1116 - 1116. [PDF]

				M. Frick, B. Darpo, J. Ostergren, and M. Rosenqvist The effect of oral magnesium, alone or as an adjuvant to sotalol, after cardioversion in patients with persistent atrial fibrillation Eur. Heart J., July 2, 2000; 21(14): 1177 - 1185. [Abstract] [PDF]

				C. M. R. Satur, S. R. Stubington, A. Jennings, K. Newton, P. G. Martin, C. Gebitekin, and D. R. Walker Magnesium Flux During and After Open Heart Operations in Children Ann. Thorac. Surg., April 1, 1995; 59(4): 921 - 927. [Abstract] [Full Text]